Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy company – PR Newswire (press release)
|
Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy company
PR Newswire (press release) TORONTO, March 8, 2018 /PRNewswire/ – Portage Biotech Inc. ("Portage" or "the Company") (Canadian Securities Exchange: PBT.U, OTC Markets : PTGEF), is pleased to announce that it has made an investment in iOx Therapeutics, Ltd. ("iOx"), a United … |
